VIII International Conference of the World Association of Sarcoidosis and other granulomatous lung diseases: current understanding of sarcoidosis

Sarcoidosis is an epithelioid cell granulomatosis system, which remains a mystery to medical science and clinical practice. Every year, the World Association of Sarcoidosis and other granulomatous lung diseases (WASOG) held a conference where the study of this disease was summarized. In 2016 the conference was held in Gdansk. The main provisions to the leading specialists in sarcoidosis. The etiology of sarcoidosis is unknown. There was a highly informative X-ray computed tomography, positron emission tomography, spirometry and lung diffusion capacity evaluation to assess the activity of the process and the dynamics of the patients. The data on the pathogenesis, prevalence and clinical significance of chronic fatigue syndrome and peripheral neuropathy fibers in sarcoidosis. Limited clinical studies conducted with the use of vasoactive intestinal peptide, antimycobacterial antibiotic for treatment of sarcoidosis. The significance of diagnosis of heart disease and pulmonary hypertension in sarcoidosis. Speakers noted that the treatment of pulmonary sarcoidosis approved only prednisolon and corticotropin. It was concluded that treatment should be initiated only with the progression of sarcoidosis threatening conditions and marked reduction in quality of life related to health.

sarcoidosis, World Association of Sarcoidosis and other granulomatous lung diseases, diagnosis, treatment and quality of life